What is the recurrence rate after treatment with Bedaquilin?
Bedaquiline (Bedaquiline) is a new type of anti-tuberculosis drug. Bedaquiline and delamanid are the first new drugs registered for the treatment of tuberculosis in 40 years. They have significant effects in the treatment of pulmonary tuberculosis. Bedaquiline can improve the cure rate and reduce the risk of recurrence. Bedaquiline selectively inhibits bacterial ATP synthase and reduces ATP production.

The recommended dosage of bedaquiline is 400 mg once a day for 2 weeks, and then 200 mg 3 times a week. mg for 22 weeks (a total of 24weeks). The incidence of hepatic adverse reactions was higher in adult and pediatric patients receiving antituberculosis regimens containing bedaquiline than in patients receiving antituberculosis regimens that did not contain bedaquiline. Monitor liver function tests(Aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) at baseline, monthly during treatment, and as needed. In addition, symptoms of abnormal liver function tests (such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly) should be monitored at baseline, monthly during treatment, and as needed. If new or worsening signs or symptoms of hepatic dysfunction occur(e.g., serum aminotransferases and/
The Russian version is the same as that of domestic imported drug manufacturers. The price in Russian hospitals is around 100mg188 tablets1 around 10,000 to 50,000. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)